Literature DB >> 8374504

Actin, tropomyosin and alpha-actinin as markers of differentiation in human rhabdomyosarcoma cell lines induced with dimethyl sulfoxide.

J Prados1, C Melguizo, J E Fernandez, A E Aranega, L Alvarez, A Aranega.   

Abstract

Most rhabdomyosarcomas are poorly differentiated malignant tumors. Dimethyl sulfoxide has been shown to modulate cell differentiation in cultured human cells. We induced differentiation in human rhabdomyosarcoma cell lines A-673, RD and A-204 with 1.25% dimethyl sulfoxide, and used desmin, the protein most frequently used as a marker of muscle cell differentiation, to trace this process. As alternative markers of the degree of differentiation, we quantified the expression of the proteins actin, tropomyosin and alpha-actinin in these cell lines, and followed the changes in expression of these proteins after induction for 8, 12, 24, 48 and 72 hrs. In the process of differentiation, protein expression in both the cytoplasm and cytoskeleton was significantly increased by treatments lasting 12 hrs. (alpha-actinin) and 24 hrs. (actin). On the basis of our results, alpha-actinin can be considered as an earlier marker of differentiation than actin in human rhabdomyosarcoma cell lines. However, the earliest indication of differentiation was a modification in desmin expression (8 hrs.). Because changes in tropomyosin expression were less marked, we consider this protein as a poor marker of rhabdomyosarcoma cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8374504

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  6 in total

Review 1.  Evolving management of colorectal cancer.

Authors:  Jochem van der Voort van Zijp; Harald J Hoekstra; Marc D Basson
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

2.  Tumor cell complementation groups based on myogenic potential: evidence for inactivation of loci required for basic helix-loop-helix protein activity.

Authors:  A N Gerber; S J Tapscott
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

3.  Influence of dimethyl sulphoxide on intermediate filament proteins in human rhabdomyosarcoma cell lines: modulation at subcellular level.

Authors:  C Melguizo; J Prados; C Velez; A E Aranega; L Alvarez; A Aranega
Journal:  Histochem J       Date:  1994-06

4.  2D-difference gel electrophoretic proteomic analysis of a cell culture model of alveolar rhabdomyosarcoma.

Authors:  Joseph G Pressey; Christine S Pressey; Gloria Robinson; Richie Herring; Landon Wilson; David R Kelly; Helen Kim
Journal:  J Proteome Res       Date:  2011-01-10       Impact factor: 4.466

5.  GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells.

Authors:  J A Marchal; J Prados; C Melguizo; J A Gómez; J Campos; M A Gallo; A Espinosa; N Arena; A Aránega
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

6.  Characterization of a new human embryonal rhabdomyosarcoma cell line, RMS-GR.

Authors:  J E Fernández; J Prados; C Melquizo; N Arena; F Malavasi; L Alvarez; A Aránega
Journal:  Jpn J Cancer Res       Date:  1998-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.